中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

70 records (took 0.027 seconds)

    Method of manufacturing a TFT array panel
    31.
    发明授权
    Method of manufacturing a TFT array panel 有权
    制造TFT阵列面板的方法

    公开(公告)号：US07998786B2

    公开(公告)日：2011-08-16

    申请号：US12369839

    申请日：2009-02-12

    Applicant: Je-Hun Lee ,  Jae-Kyeong Lee ,  Chang-Oh Jeong ,  Beom-Seok Cho

    Inventor： Je-Hun Lee ,  Jae-Kyeong Lee ,  Chang-Oh Jeong ,  Beom-Seok Cho

    IPC: H01L21/00

    CPC classification number: H01L29/66765 ,  H01L27/12 ,  H01L29/458 ,  H01L29/4908

    Abstract: Multi-layered wiring for a larger flat panel display is formed by depositing molybdenum on a substrate in presence of a precursor gas containing at least one oxygen, nitrogen and carbon to form a molybdenum layer. An aluminum layer is deposited on the molybdenum layer. Another metal layer may be formed on the aluminum layer. The molybdenum layer has a face-centered cubic (FCC) lattice structure with a preferred orientation of (111).

    Abstract translation: 在含有至少一个氧，氮和碳的前体气体的存在下，在基板上沉积钼以形成钼层，形成用于较大平板显示器的多层布线。 铝层沉积在钼层上。 可以在铝层上形成另一金属层。 钼层具有面心立方（FCC）晶格结构，其优选取向为（111）。

    2′-fluoronucleosides
    35.
    发明授权
    2′-fluoronucleosides 有权
    2'-核糖核苷

    公开(公告)号：US07662938B2

    公开(公告)日：2010-02-16

    申请号：US11942551

    申请日：2007-11-19

    Applicant: Raymond F. Schinazi ,  Dennis C. Liotta ,  Chung K. Chu ,  J. Jeffrey McAtee ,  Junxing Shi ,  Yongseok Choi ,  Kyeong Lee ,  Joon H. Hong

    Inventor： Raymond F. Schinazi ,  Dennis C. Liotta ,  Chung K. Chu ,  J. Jeffrey McAtee ,  Junxing Shi ,  Yongseok Choi ,  Kyeong Lee ,  Joon H. Hong

    IPC: C07G3/00 ,  C07H21/00 ,  C07H21/02 ,  C12Q1/68

    CPC classification number: A61K31/7076 ,  A61K31/706 ,  A61K31/7064 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/708 ,  C07D405/04 ,  C07D473/00 ,  C07H19/06 ,  C07H19/10 ,  C07H19/16

    Abstract: A class of 2′-fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formula: wherein Base is a purine or pyrimidine base; R1 is OH, H, OR3, N3, CN, halogen, including F, or CF3, lower alkyl, amino, lower alkylamino, di(lower)alkylamino, or alkoxy, and base refers to a purine or pyrimidine base; R2 is H, phosphate, including monophosphate, diphosphate, triphosphate, or a stabilized phosphate prodrug; acyl, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of providing a compound wherein R2 is H or phosphate; sulfonate ester including alkyl or aryalkyl sulfonyl including methanesulfonyl, benzyl, wherein the phenyl group is optionally substituted with one or more substituents as described in the definition of aryl given above, a lipid, an amino acid, peptide, or cholesterol; and R3 is acyl, alkyl, phosphate, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of being cleaved to the parent compound, or a pharmaceutically acceptable salt thereof.

    Abstract translation: 公开了一类可用于治疗乙型肝炎感染，丙型肝炎感染，HIV和异常细胞增殖（包括肿瘤和癌症）的2'-氟 - 核苷化合物。 所述化合物具有以下通式：其中碱是嘌呤或嘧啶碱; R 1是OH，H，OR 3，N 3，CN，卤素，包括F或CF 3，低级烷基，氨基，低级烷基氨基，二（低级）烷基氨基或烷氧基，碱是指嘌呤或嘧啶碱基; R2是H，磷酸盐，包括单磷酸盐，二磷酸盐，三磷酸盐或稳定的磷酸盐前体药物; 酰基或其它药学上可接受的离去基团，其在体内施用时能够提供其中R 2为H或磷酸酯的化合物; 磺酸酯，包括烷基或芳烷基磺酰基，包括甲磺酰基，苄基，其中苯基任选被一个或多个取代基取代，如上文给出的芳基的定义，脂质，氨基酸，肽或胆固醇; 并且R3是酰基，烷基，磷酸酯或其它药学上可接受的离去基团，当其在体内施用时，能够被切割成母体化合物或其药学上可接受的盐。

    TFT ARRAY PANEL
    36.
    发明申请
    TFT ARRAY PANEL 有权
    TFT阵列面板

    公开(公告)号：US20090163022A1

    公开(公告)日：2009-06-25

    申请号：US12369839

    申请日：2009-02-12

    Applicant: Je-Hun LEE ,  Jae-Kyeong LEE ,  Chang-Oh JEONG ,  Beom-Seok CHO

    Inventor： Je-Hun LEE ,  Jae-Kyeong LEE ,  Chang-Oh JEONG ,  Beom-Seok CHO

    IPC: H01L21/4763

    CPC classification number: H01L29/66765 ,  H01L27/12 ,  H01L29/458 ,  H01L29/4908

    Abstract: Multi-layered wiring for a larger flat panel display is formed by depositing molybdenum on a substrate in presence of a precursor gas containing at least one oxygen, nitrogen and carbon to form a molybdenum layer. An aluminum layer is deposited on the molybdenum layer. Another metal layer may be formed on the aluminum layer. The molybdenum layer has a face-centered cubic (FCC) lattice structure with a preferred orientation of (111).

    Abstract translation: 在含有至少一个氧，氮和碳的前体气体的存在下，在基板上沉积钼以形成钼层，形成用于较大平板显示器的多层布线。 铝层沉积在钼层上。 可以在铝层上形成另一金属层。 钼层具有面心立方（FCC）晶格结构，其优选取向为（111）。

    2'-FLUORONUCLEOSIDES
    37.
    发明申请
    2'-FLUORONUCLEOSIDES 有权
    2'-氟核苷酸

    公开(公告)号：US20080300398A1

    公开(公告)日：2008-12-04

    申请号：US11942551

    申请日：2007-11-19

    Applicant: Raymond F. Schinazi ,  Dennis C. Liotta ,  Chung K. Chu ,  J. Jeffrey McAtee ,  Junxing Shi ,  Yongseok Choi ,  Kyeong Lee ,  Joon H. Hong

    Inventor： Raymond F. Schinazi ,  Dennis C. Liotta ,  Chung K. Chu ,  J. Jeffrey McAtee ,  Junxing Shi ,  Yongseok Choi ,  Kyeong Lee ,  Joon H. Hong

    IPC: C07H1/00

    CPC classification number: A61K31/7076 ,  A61K31/706 ,  A61K31/7064 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/708 ,  C07D405/04 ,  C07D473/00 ,  C07H19/06 ,  C07H19/10 ,  C07H19/16

    Abstract: A class of 2′-fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae: wherein Base is a purine or pyrimidine base; R1 is OH, H, OR3, N3, CN, halogen, including F, or CF3, lower alkyl, amino, lower alkylamino, di(lower)alkylamino, or alkoxy, and base refers to a purine or pyrimidine base; R2 is H, phosphate, including monophosphate, diphosphate, triphosphate, or a stabilized phosphate prodrug; acyl, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of providing a compound wherein R2 is H or phosphate; sulfonate ester including alkyl or aryalkyl sulfonyl including methanesulfonyl, benzyl, wherein the phenyl group is optionally substituted with one or more substituents as described in the definition of aryl given above, a lipid, an amino acid, peptide, or cholesterol; and R3 is acyl, alkyl, phosphate, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of being cleaved to the parent compound, or a pharmaceutically acceptable salt thereof.

    Abstract translation: 公开了一类可用于治疗乙型肝炎感染，丙型肝炎感染，HIV和异常细胞增殖（包括肿瘤和癌症）的2'-氟 - 核苷化合物。 所述化合物具有以下通式：其中碱是嘌呤或嘧啶碱; R 1是OH，H，OR 3，N 3，CN，卤素，包括F或CF 3，低级烷基，氨基，低级烷基氨基，二（低级）烷基氨基或烷氧基，碱是指嘌呤或嘧啶碱基; R2是H，磷酸盐，包括单磷酸盐，二磷酸盐，三磷酸盐或稳定的磷酸盐前体药物; 酰基或其它药学上可接受的离去基团，其在体内施用时能够提供其中R 2为H或磷酸酯的化合物; 磺酸酯，包括烷基或芳烷基磺酰基，包括甲磺酰基，苄基，其中苯基任选被一个或多个取代基取代，如上文给出的芳基的定义，脂质，氨基酸，肽或胆固醇; 并且R3是酰基，烷基，磷酸酯或其它药学上可接受的离去基团，当其在体内施用时，能够被切割成母体化合物或其药学上可接受的盐。

    Substrate treating apparatus and substrate treating method using the same
    38.
    发明申请
    Substrate treating apparatus and substrate treating method using the same 审中-公开
    基板处理装置及使用其的基板处理方法

    公开(公告)号：US20060163207A1

    公开(公告)日：2006-07-27

    申请号：US11184357

    申请日：2005-07-18

    Applicant: Young-sig Lee ,  Ki-hyun Kim ,  Hong-je Cho ,  Kwan-Tack Lim ,  Jae-kyeong Lee

    Inventor： Young-sig Lee ,  Ki-hyun Kim ,  Hong-je Cho ,  Kwan-Tack Lim ,  Jae-kyeong Lee

    IPC: B05D7/00 ,  C03C15/00 ,  B05C5/00 ,  C23F1/00 ,  B05D1/02

    CPC classification number: H01L21/6708 ,  B05B13/0221

    Abstract: Disclosed is a substrate treating apparatus including a treatment solution dispenser supplying a treatment solution on a substrate, a transporting unit transporting the substrate, and a controller controlling the transporting unit so that the substrate is transported in an inclined position. The substrate is inclined sideways through a rotation with respect to an axis extending parallel to a transportation direction of the substrate. The rotation may be made in both directions in an alternating manner. The apparatus is useful for treating the substrate uniformly regardless of substrate size.

    Abstract translation: 公开了一种基板处理装置，其包括在基板上供给处理溶液的处理液分配器，输送基板的输送单元和控制输送单元的控制器，使得基板在倾斜位置被输送。 基板相对于平行于基板的输送方向延伸的轴线的旋转侧向倾斜。 旋转可以以交替的方式在两个方向上进行。 该设备可用于均匀地处理衬底，而与衬底尺寸无关。

    2′-Fluoronucleosides
    39.
    发明授权
    2′-Fluoronucleosides 有权
    2'-氟核苷

    公开(公告)号：US06348587B1

    公开(公告)日：2002-02-19

    申请号：US09257130

    申请日：1999-02-25

    Applicant: Raymond F. Schinazi ,  Dennis C. Liotta ,  Chung K. Chu ,  J. Jeffrey McAtee ,  Junxing Shi ,  Yongseok Choi ,  Kyeong Lee ,  Joon H. Hong

    Inventor： Raymond F. Schinazi ,  Dennis C. Liotta ,  Chung K. Chu ,  J. Jeffrey McAtee ,  Junxing Shi ,  Yongseok Choi ,  Kyeong Lee ,  Joon H. Hong

    IPC: C07H2102

    CPC classification number: A61K31/7076 ,  A61K31/706 ,  A61K31/7064 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/708 ,  C07D405/04 ,  C07D473/00 ,  C07H19/06 ,  C07H19/10 ,  C07H19/16

    Abstract: A class of 2′-fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae: wherein Base is a purine or pyrimidine base; R1 is OH, H, OR3, N3, CN, halogen, including F, or CF3, lower alkyl, amino, loweralkylamino, di(lower)alkylamino, or alkoxy, and base refers to a purine or pyrimidine base; R2 is H, phosphate, including monophosphate, diphosphate, triphosphate, or a stabilized phosphate prodrug; acyl, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of providing a compound wherein R2 is H or phosphate; sulfonate ester including alkyl or arylalkyl sulfonyl including methanesulfonyl, benzyl, wherein the phenyl group is optionally substituted with one or more substituents as described in the definition of aryl given above, a lipid, an amino acid, peptide, or cholesterol; and R3 is acyl, alkyl, phosphate, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of being cleaved to the parent compound, or a pharmaceutically acceptable salt thereof.

    Abstract translation: 公开了一类可用于治疗乙型肝炎感染，丙型肝炎感染，HIV和异常细胞增殖（包括肿瘤和癌症）的2'-氟 - 核苷化合物。 该化合物具有以下通式：其中碱是嘌呤或嘧啶碱; R1是OH，H，OR3，N3，CN，卤素，包括F或CF3，低级烷基，氨基，低级烷基氨基，二（低级）烷基氨基或烷氧基，碱是指嘌呤或嘧啶碱; R2是H， 磷酸盐，包括单磷酸盐，二磷酸盐，三磷酸盐或稳定化的磷酸盐前体药物; 酰基或其它药学上可接受的离去基团，其在体内施用时能够提供其中R 2为H或磷酸酯的化合物; 磺酸酯，包括烷基或芳基烷基磺酰基，包括甲磺酰基，苄基，其中苯基任选被一个或多个取代基取代，如上述芳基定义中所述，脂质，氨基酸，肽或胆固醇; 和R 3是酰基，烷基，磷酸酯或其它药学上可接受的离去基团，当其在体内施用时，其能够被切割成母体化合物或其药学上可接受的盐。

Patent Agency Ranking